New collagen filler aims to smooth wrinkles and scars

NCT ID NCT06336044

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new injectable filler made from hyaluronic acid and collagen to improve wrinkles, scars, and skin looseness on the face. Forty non-smoking adults aged 18-70 will receive one treatment and be followed for 16 weeks. Researchers will check for side effects and measure changes in skin appearance and hydration.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hyaluronic acid and recombinant collagen filler (Karisma)
What this could lead to
If successful, this could offer a safe and effective option for reducing wrinkles, scars, and skin looseness.
What could go wrong
This is a small, early study with no control group. Results may not apply to all skin types or ages. Side effects like swelling or bruising are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAXITY; SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ospedale Tor Vergata

    RECRUITING

    Roma, 00133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.